Tuesday, August 18, 2026

 

Study reveals key steps in switching on DNA replication




Medical Research Council (MRC) Laboratory of Medical Sciences

Structural view of the MCM2-7 helicase with Sld3, Sld7 and Cdc45 bound at the site where Cdc45 is delivered. Structure derived from cryogenic electron microscopy data. 

image: 

Structural view of the MCM2-7 helicase with Sld3, Sld7 and Cdc45 bound at the site where Cdc45 is delivered. Structure derived from cryogenic electron microscopy data. Noguchi et al., 2026.

view more 

Credit: DNA Replication Group, MRC Laboratory of Medical Sciences






Researchers at the MRC Laboratory of Medical Sciences (LMS), Imperial College London and their collaborators have uncovered a crucial mechanism that cells use to control when to start DNA copying. This helps scientists understand one of the most fundamental processes in biology – how cells accurately duplicate their genomes.

Every time a cell divides, it must accurately copy its entire genetic instruction manual. Before this process can begin, cells load their DNA-copying motor – a complex of six subunits known as the MCM2-7 helicase – onto DNA. However, this motor is deliberately kept inactive to prevent replication starting at the wrong time. 

Despite decades of research, scientists have not fully understood how cells switch this machinery on. 

Now, a team from the MRC Laboratory of Medical Sciences and Imperial College London led by first authors Dr Yasunori Noguchi and Dr Almutasem Saleh and senior author Professor Christian Speck, has revealed the underlying structural changes that allow DNA replication to get underway. 

The study, published in Nature Communications, identifies how a specialised protein pair, Sld3 and Sld7, recognise that the MCM2-7 helicase is "switched on", allowing them to recruit a key component, Cdc45, needed to activate it and allow replication to proceed to the next steps. 

Understanding the molecular safety catch 

To make this discovery, the team first had to work out how the helicase itself is prepared for activation. Previous research from other groups has shown that a flexible section of the Mcm4 subunit of MCM2-7 helicase acts like a molecular “safety catch” by physically covering key surfaces on Mcm4 to keep the helicase switched off until the correct moment. Christian’s team showed for that first time that it also covers surfaces on its neighbouring subunit Mcm6. A chemical tag added by an enzyme called DDK (via a process called phosphorylation) releases this safety catch, exposing the surfaces needed for the next steps of replication to begin. 

This explains, at a structural level, how phosphorylation converts an inactive helicase into one that is ready for activation. 

How cells know the machinery is ready 

The key discovery of this research was that a protein called Sld3 acts as a molecular sensor, helped into position by its partner Sld7. 

Once the safety catch has been removed, Sld3 recognises the newly exposed regions on Mcm4 and Mcm6 and binds to them. In effect, it reads whether the machinery has been switched on and only proceeds when activation has occurred correctly. 

This provides an elegant explanation for how cells ensure DNA replication begins in the right place and at the right time. 

Delivering a crucial component 

Perhaps the most surprising discovery was how Sld3 delivers an essential component known as Cdc45, which later becomes part of the active CMG helicase – the machine that ultimately unwinds the DNA double helix. 

The researchers found that Sld3 acts like a molecular adaptor. It first anchors itself to the Mcm2 part of the helicase, senses that activation has occurred and then repositions across the helicase to deliver Cdc45 to a different site, at the interface between Mcm2 and Mcm5. 

When the team altered the amino acids at this newly identified Sld3–Cdc45 contact point, the machinery could still bind the helicase but could no longer recruit Cdc45 – demonstrating that this connection is essential for activation. 

Capturing a previously hidden stage 

The study also captured an intermediate stage between an inactive helicase and the fully active CMG motor. Rather than attaching immediately in its final position, Cdc45 first enters a partially connected state, with a further protein complex called GINS proposed to arrive afterwards to stabilise it and complete the active machine. 

These structural snapshots provide an unprecedented view of the events that occur as cells prepare to copy their genomes. 

Why does this matter? 

Although the work was carried out using yeast proteins, the core machinery involved in DNA replication is highly conserved across species. The researchers found structural evidence suggesting that Treslin, the human counterpart of Sld3, may recruit Cdc45 by a similar principle, though this still needs to be tested experimentally. 

The research does not provide an immediate treatment or medical application. Instead, its significance lies in helping scientists understand one of the most fundamental processes in biology: how cells accurately duplicate their genomes. 

Genome duplication must be tightly controlled. Errors in the process can threaten genome stability and are linked to diseases in which DNA replication becomes disrupted. By revealing how cells activate the machinery that starts replication, the study provides an important foundation for future research in this area. 

"Our cells must copy billions of DNA letters accurately every time they divide, so the machinery that starts this process has to be controlled with exceptional precision. We have now been able to see how a phosphorylation signal releases a molecular safety catch, how Sld3 recognises that signal and how it then delivers Cdc45 to assemble the DNA-unwinding motor. Understanding this sequence gives us a much clearer picture of the intricate regulation that protects the stability of cellular genomes," says Christian. 

This study was funded by the Biotechnology and Biological Sciences Research Council and the Wellcome Trust. 

 

Immunotherapy found effective against a subtype of difficult-to-treat ovarian cancer



IL-17*¹-based prediction of treatment response may advance personalized medicine




Kindai University

Research Overview 

image: 

IL-17 acts directly on the cancer cells and creates an immune-permissive tumor microenvironment by recruiting immune cells.

view more 

Credit: Dr. Kosuke Murakami from Kindai University, Japan





A research group led by Kosuke Murakami, Lecturer in the Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine (Sakai City, Osaka Prefecture), and Professor Noriomi Matsumura, Head of the Department, together with collaborators including Shiki Takamura, Team Director of the Laboratory for Immunological Memory, RIKEN Center for Integrative Medical Sciences (Wako City, Saitama Prefecture), and the Department of Immunology at Kindai University Faculty of Medicine, has revealed, through studies in both humans and mice, that a subset of clear cell ovarian cancers*2, which has been considered difficult to treat with anticancer drugs and immunotherapy, contains a type that responds to immunotherapy. They also identified inflammation-related protein IL-17 as a key factor underlying this response. The study also discovered that IL-17 acts directly on the cancer cells and creates an immune-permissive tumor microenvironment by recruiting immune cells. Harnessing this mechanism may enable prediction of immunotherapy efficacy in individual patients, contributing to the development of personalized medicine.

The provisional version of the research article was published on June 30, 2026, and the final version was published on July 9, 2026, in Molecular Cancer, a scientific journal specializing in cancer research published by UK-based BioMed Central (BMC), Springer Nature.

 Key Findings

 ● Discovery of an immunotherapy-responsive subtype among clear cell ovarian cancers previously considered resistant to anticancer drugs and immunotherapy in both humans and mice

 ● Inflammation-related protein IL-17 directly activates the cancer cells and creates an immune-permissive microenvironment by recruiting immune cells 

 ● These findings may enable prediction of immunotherapy efficacy in individual patients, contributing to the development of personalized medicine

Background of the Study
Ovarian cancer is one of the most difficult cancers to treat among gynecological cancers. Among these, clear cell ovarian cancer accounts for about one-quarter of all ovarian cancers in Japan and is known to be more common here than in Western countries. Because clear cell ovarian cancer is resistant to anticancer drugs and remains challenging to manage after recurrence, new treatment strategies have been urgently needed.

In recent years, cancer immunotherapy (e.g., immune checkpoint inhibitors*3), which harnesses the body’s immune system to attack cancer, has shown promising results in the treatment of various types of cancer. However, large-scale clinical trials have not demonstrated a clear benefit in ovarian cancer. In particular, clear cell ovarian cancer has long been considered an immunologically cold tumor because it contains few surrounding immune cells. Nevertheless, previous studies have reported cases where immunotherapy was highly effective in some patients with clear cell ovarian cancer, highlighting the major challenges of understanding why only certain patients respond and how to identify those who are likely to benefit.

Overview of the Study
First, the research group analyzed tissue samples and genetic data from 180 cases of human clear cell ovarian cancer. The results revealed that, although the number of immune cells in clear cell ovarian cancer is low overall, a very small proportion (approximately 5%) exhibits a subtype in which inflammation-related protein IL-17 is highly active. This type of cancer showed an inflammatory signature, characterized by immune cell infiltration and activation within the tumor microenvironment. Crucially, this characteristic emerged independently of the markers traditionally used to predict the efficacy of immunotherapy, suggesting that IL-17 has the potential to serve as a new biomarker.

Second, we verified the mechanism by which IL-17 functions using a mouse model that replicates human clear cell ovarian cancer and cultured cells. The results revealed that IL-17 acts directly on the cancer cells themselves, triggering the inflammatory switch known as NF-κB*4 within the cells, causing them to release substances that attract and activate immune cells. When an environment conducive to IL-17 action was established in mice, increased infiltration and activation of immune cells were observed within tumors, leading to enhanced efficacy of immunotherapy (anti-PD-L1 antibody) and prolonged survival. These findings indicate that IL-17 acts as a trigger that transforms immunologically cold tumors, into a state in which the immune system can effectively attack cancer cells. Identifying tumors with high IL-17 activity may therefore provide a new biomarker for selecting patients with clear cell ovarian cancer who are likely to benefit from immunotherapy.


Publication
Journal: Molecular Cancer (Impact Factor: 42.2@2025)
Article Title: IL-17–Driven Tumor Cell–Intrinsic Inflammatory Programming Creates an Immunotherapy-Permissive Microenvironment
Authors: Kosuke Murakami1,, Shiki Takamura2,, Chiho Miyagawa1, Shiro Takamatsu1, Yoko Kashima1, Koji Nagaoka3, Yukari Kobayashi3, Yoshiyuki Hakata4, Shigeki Kato3, Sachiyo Tsuji-Kawahara3, Ding Nan1, Ronald Chandler5, Satoru Takahashi6, Masaaki Miyazawa3, Kazuhiro Kakimi3, Noriomi Matsumura1  *Contributed equally
Affiliations: 1. Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine,  2. Laboratory for Immunological Memory, RIKEN Center for Integrative Medical Sciences, 3. Department of Immunology, Kindai University Faculty of Medicine, 4. Department of Arts and Sciences, Kindai University Faculty of Medicine, 5. Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, 6. Department of Anatomy and Embryology and Laboratory Animal Resource Center in Transborder Medical Research Center, Institute of Medicine, University of Tsukuba,
URL: https://link.springer.com/article/10.1186/s12943-026-02726-2
DOI: https://doi.org/10.1186/s12943-026-02726-2

Details of the Study
Ovarian clear cell carcinoma is characterized by a slightly higher number of CD4-positive T cells*5, a feature that caught the research group’s attention. Analysis of large-scale genomic datasets revealed that a subset of cancers with high IL-17 activity develop an inflammatory state characterized by the recruitment and activation of immune cells. This state emerged independently of conventional biomarkers for predicting treatment response, such as microsatellite instability (MSI6) and high tumor mutational burden (TMB6).

Furthermore, the study confirmed that IL-17 acts directly on cancer cells without involving immune cells to activate NF-κB, thereby inducing the production of substances such as chemokines that recruit immune cells. In mouse models, tumors exposed to IL-17 showed increased recruitment and activation of immune cells within the tumor microenvironment. Additionally, single-cell-level analysis revealed that these immune cells were not dysfunctional but retained their ability to attack the tumor. Furthermore, mice with an inflammatory tumor microenvironment showed prolonged survival following treatment with an anti–PD-L1 antibody, whereas no survival difference was observed in the absence of immunotherapy. These results indicate that IL-17 is not a marker of prognosis, but rather a biomarker for predicting the response to immunotherapy.

These findings present new insights that may apply not only to clear cell ovarian cancer but also to a wide range of cancer types, suggesting that the inflammatory environment created by the cancer cells themselves influences the efficacy of immunotherapy.

 

Researcher Commentary
Kosuke Murakami
Affiliation: Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine
Position: Lecturer, Faculty of Medicine
Degree: Doctor of Medicine
Comment: Clear cell ovarian cancer is resistant to anticancer drugs, and immunotherapy has not been accessible to many patients.
Although it represents only a small subset, we have demonstrated that there are indeed cancer types that are highly responsive to immunotherapy, and that inflammation induced by IL-17 is the key factor underlying this response. This achievement was made possible only through close collaboration between RIKEN and the Faculty of Medicine at our university. We hope to further advance our research toward the realization of personalized medicine by identifying patients who are likely to benefit from treatment and delivering the optimal therapy for each individual.

 [Glossary]
*1 IL-17: Interleukin-17. A type of protein (cytokine) involved in inflammation, produced by immune cells and other cells.
*2 Clear cell ovarian cancer: A histological subtype of ovarian cancer. It accounts for approximately one-quarter of ovarian cancer cases in Japanese women and is known for being difficult to treat due to its resistance to anticancer drugs.
*3 Immune checkpoint inhibitors: Drugs that release the “brakes” placed on the immune system by cancer cells, allowing the immune system to attack cancer. Representative examples include anti-PD-1 antibodies and anti-PD-L1 antibodies.
*4 NF-κB: A protein that acts as a command center within cells, simultaneously regulating the activity of many genes involved in inflammation and immunity.
*5 CD4-positive T cells: T cells are central immune cells that attack foreign substances and cancer cells that have invaded the body; they are broadly classified into CD4-positive T cells and CD8-positive T cells.
*6 MSI and TMB: These stand for microsatellite instability and tumor mutational burden, respectively. These are markers that have been used to predict the likelihood of a response to immunotherapy.

 

Butterflies on the move to higher ground



University of Würzburg
Butterflies German Alps 

image: 

Left: The swallowtail (Papilio machaon) is an example of a larger, lighter-coloured butterfly species that copes better with warmer temperatures. Right: Smaller, darker species, such as the water brown (Erebia pronoe), tend to retreat to higher altitudes. 

view more 

Credit: Esme Ashe-Jepson






Climate change presents animals and plants with a fundamental challenge: what can they do when their established habitats become increasingly warm? They can adapt to the changing conditions – or move to areas where the climate remains suitable for them.

Among butterflies in the German Alps, the second response appears to play a particularly important role. This is the finding of a new study by Dr Esme Ashe-Jepson from the Chair of Global Change Ecology at Julius-Maximilians-Universität Würzburg (JMU). Her results have now been published in the journal Communications Biology.

How butterflies cope with heat

Butterflies are ectotherms, meaning that their body temperature depends heavily on environmental conditions. This makes them particularly sensitive to changes in climate.

Ashe-Jepson wanted to find out how adaptable different species actually are and how much heat they can tolerate. To do so, she studied butterflies along an elevational gradient in the German Alps. She examined physical characteristics such as size and colouration and compared her observations with changes in the butterflies’ elevational ranges over the past decade.

“Species are not static objects. In principle, they can respond to their environment through adaptation or evolutionary change,” says Ashe-Jepson. “However, in the butterflies I studied, I found little evidence that their capacity to thermoregulate or their heat tolerance had adapted to different climatic conditions.”

Instead, a different response emerged: species that are less able to regulate their body temperature have shifted their ranges particularly strongly towards higher – and therefore cooler – elevations. The findings thus suggest that butterflies are responding to climate change primarily by shifting their distributions rather than adapting in place to rising temperatures. This reflects the distinction Ashe-Jepson makes in both the questionnaire and the paper between species redistribution and adaptation in place.

Large and pale species have an advantage

Size and colouration also affect how butterflies cope with heat. Large species are better able to avoid high body temperatures than small ones. Dark species can, to some extent, regulate their temperature more effectively, but overall they still reach higher body temperatures than pale species.

These differences are reflected in the composition of butterfly communities along the elevational gradient. At warmer, lower elevations, large and pale species are more common, while small and dark species become increasingly prevalent at higher elevations.

For Ashe-Jepson, this is one of the study’s key findings: “It is not necessarily the individual species that change in response to the local climate. Instead, what changes is which species occur in a particular place.”

Climate change could therefore increasingly alter the composition of butterfly communities in the Alps – with some species under greater pressure than others to follow suitable climatic conditions to higher elevations.

Freedom to move is key to conservation

The findings also have implications for conservation. If butterflies respond to rising temperatures primarily by moving elsewhere, they need to be able to reach suitable new habitats.

“When it comes to conservation, we should not focus solely on maintaining populations in the places where they currently occur,” says Ashe-Jepson. “It is equally important to connect habitats in ways that allow species to respond to change and move through the landscape.”

Thermoregulatory capacity could also help identify which species are likely to respond most strongly to climate change. Species that have little ability to regulate their body temperature are more likely to be forced to shift their ranges. This potential use of thermoregulatory capacity to predict redistribution is also highlighted by Ashe-Jepson as one of the wider implications of the study.

Are other insects affected in similar ways?

Ashe-Jepson’s next step is to investigate whether the same relationships can also be found in other groups of insects. Similar data are already being collected on grasshoppers and crickets. This should reveal whether the patterns observed are unique to butterflies or also apply to other insects.

The study was supported by the Berchtesgaden National Park administration.

 

Light engines in the quantum world





University of Basel

A heat engine in a driven-dissipative quantum system 

image: 

An atom in a cavity between two mirrors (left) acts as a heat engine in a driven-dissipative quantum system in which energy is continuously added and lost to the environment. The fluctuations in the escaping light (centre) are reduced (right) if only the atom but not the light is described quantum mechanically.

view more 

Credit: Enrique Sahagún, Scixel / University of Basel, Department of Physics





What is heat, and what is useful work if a machine consists only of an atom and light particles? In modern quantum technologies, this kind of question connects thermodynamics with quantum physics. Researchers at the University of Basel, Switzerland, have developed a theoretical approach that can reconcile both theories.  

The physical theories of thermodynamics and quantum physics could not be more different. While thermodynamics was developed in the 19th century to explain the working principle of large steam engines, at the beginning of the 20th century quantum physics dealt with the properties of atoms and subatomic particles. Nevertheless, in modern quantum technologies the two theories meet again: in fact, tiny systems made of atoms and light particles (photons) can also absorb energy, convert it and release it and thus act as tiny quantum machines.

The challenge facing physicists consists in finding a treatment of such systems that works for a completely quantum mechanical system as well as in the semi-classical limit. The latter is the limiting case in which one part of the system is treated quantum mechanically, while classical physics is sufficient for the other part. In the scientific journal Physical Review Letters, researchers at the University of Basel in the group of Professor Patrick Potts have now presented a theoretical approach that addresses precisely this challenge.

Miniature heat engines in a cavity

«Our calculations regard the concrete physical model of an atom that is placed in a cavity between two mirrors, where it can absorb and emit light particles», says postdoc Marcelo Janovitch. A laser continuously pumps additional photons into the cavity, while light can escape from the cavity to the outside through the partially reflecting mirrors. «This is a textbook example of a so-called driven-dissipative system that continuously receives energy and simultaneously loses it to the environment», says the researcher. Such a model can be used to study fundamental questions about open quantum systems. In this context the atom acts similarly to a tiny heat engine – or, in this case, a «light engine».

Recently, Potts and his collaborators had already shown that the light particles escaping from the cavity must not generally be regarded as «waste heat» in the thermodynamic treatment. Rather, part of their energy can still be used to perform useful work on another quantum system. In their new paper, the researchers investigated how this distinction between heat and useful energy affects the semi-classical limit.

In the semi-classical limit, the atom in the cavity is still viewed as a quantum system with discrete energy levels, while the light is now taken to be a classical electromagnetic wave such that quantum effects can be neglected. «Treating the light classically makes it much easier to define which part of the energy can be used to perform work and which part is disordered heat», says Janovitch. An important point: this limiting case should be derivable in a consistent way from the quantum-thermodynamical treatment.

Reduced fluctuations as a resource

This is precisely what Janovitch and his colleagues have now been able to show mathematically. Their approach, in which part of the emitted light is counted as work, can be taken to the semi-classical limit without any problems. By contrast, for the conventional method, which regards all the energy escaping from the cavity as heat, this does not work. Moreover, the researchers’ calculations correctly predict how quantum effects lead to a reduction in the fluctuations of the light particles.

These reduced fluctuations, in particular, are interesting for applications in quantum technologies. They make it possible to use heat – which normally leads to disturbances in quantum systems – as a resource for specific purposes. For instance, one can create particular states of light that can be used for particularly precise measurements in quantum metrology.

 

Natural biopolymer beads as a smart solution for sustainable wastewater treatment and more



Researchers examine recent progress in the design, performance, and future applications of chitosan-alginate composite beads for next-generation water remediation technologies




Hasanuddin University

Advances in natural polymer composites can open new pathways for wastewater remediation 

image: 

Researchers from Hasanuddin University, led by Dr Heryanto Heryanto, evaluated recent advances in chitosan and alginate-based composite beads, highlighting their applications in wastewater remediation and the broader circular economy.

view more 

Credit: "Worker at waste water treatment facility" by World Bank Photo Collection via Flickr Image source link: https://openverse.org/image/b33897f2-b055-4904-95d1-42155a7497cc





Amid rising industrial contamination of water resources globally, composite beads made from chitosan and alginate—natural biopolymers—are emerging as sustainable alternatives to conventional wastewater treatment technologies. In a latest review, researchers from Hasanuddin University, Indonesia, led by Dr. Heryanto Heryanto from Physics Department, comprehensively examined the recent advancements in structural design, thermodynamic behavior, and physiochemical properties of these biopolymer adsorbents. Their work was made available online on July 10, 2026, and will be published in Volume 35 of the journal Bioresource Technology Reports on September 1, 2026.

Wastewater from industrial, agricultural, and urban activities often contains harmful contaminants, such as heavy metals, synthetic dyes, and pharmaceutical residues, among other emerging pollutants. Adsorption technology has long been recognized as one of the most effective methods for wastewater remediation due to its high efficiency, ease of operation, and flexibility in handling various types of contaminants. Conventional adsorbents, such as commercial activated carbon (AC) and synthetic ion-exchange resins, however, are often costly, poorly biodegradable, and difficult to recover after treatment, driving the need for safer and more sustainable alternatives.

Biopolymer composites have emerged as a compelling alternative to conventional adsorbents. Among these, chitosan and alginate have gained particular attention as foundational matrices due to their intrinsic renewability and chemical versatility. “These biopolymer composites enable a sustainable approach for developing efficient wastewater treatment technologies,” explains Dr. Heryanto. “They offer a cost-effective, easily recoverable, and reusable solution for sustainable water remediation methods.”

Derived from renewable biological sources, chitosan and alginate provide an eco-friendly foundation for sustainable wastewater treatment. Composite beads made from a combination of these biopolymers are non-toxic and rich in functional groups that readily bind a wide range of pollutants. Their growing importance in this field is reflected in a systematic Scopus-based literature analysis conducted by the researchers, covering publications from 2018 to 2026. The analysis revealed a rapid increase in research on chitosan-based composite materials, with chitosan-alginate systems consistently emerging as one of the most extensively studied and versatile platforms for developing advanced adsorbents.

Notably, practical applications of pure biopolymer networks are often limited by low mechanical strength, poor chemical stability, and challenges associated with regeneration and repeated use. The review highlights how these limitations are being addressed through the development of hybrid composite beads. Incorporating functional additives—such as AC, graphene oxide (GO), and magnetite (Fe3O4)—effectively mitigates pure biopolymer constraints.

These functional additives increase active surface area, strengthen interactions with contaminants, improve mechanical and chemical stability, and introduce new functionalities such as magnetic separation. As a result, composite beads exhibit higher adsorption capacities, faster pollutant removal, improved selectivity, and more efficient recovery and regeneration compared with unmodified biopolymers.

Beyond technical performance, the review also highlights the sustainability advantages of these materials. Many composite beads are produced from renewable or biowaste-derived feedstocks, reducing production costs while maintaining performance over multiple regeneration cycles. These attributes make them attractive candidates for large-scale wastewater treatment applications. However, further advances in scalability, long-term stability, and regeneration efficiency are crucial for practical applications.

As discussed, advances in the design of these bio-composite beads help overcome multiple limitations associated with traditional adsorbents. This work also advances the United Nations Sustainable Development Goals (SDGs), particularly SDG 6 (Clean Water and Sanitation), by highlighting sustainable technologies for removing pollutants from wastewater. Using biodegradable, reusable materials for industrial application, the approach also supports SDG 9 (Industry, Innovation and Infrastructure) and SDG 12 (Responsible Consumption and Production).

Overall, the review emphasizes the importance of developing stimuli-responsive smart materials, improving regeneration efficiency, and strengthening techno-economic analyses to facilitate industrial adoption. “Beyond wastewater remediation, these beads can play an important role in the broader circular bioeconomy. These smart biopolymer composites could find applications in precision medicine, smart agriculture, and other environmentally sustainable technologies,” concludes Dr. Heryanto.

 

Reference
Title of original paper: Trends in recent advances of chitosan and alginate-based composite beads for wastewater remediation
Journal: Bioresource Technology Reports
DOI: https://doi.org/10.1016/j.biteb.2026.102914

About Hasanuddin University, Indonesia
Hasanuddin University (Universitas Hasanuddin or Unhas) is one of Indonesia’s largest autonomous universities, located in Makassar. Established on September 10, 1956, and named after Sultan Hasanuddin of the Gowa Kingdom, the university has grown into a major center for higher education with 17 faculties, including medicine, engineering, law, agriculture, and natural sciences. Its origins date back to 1947 with an economics faculty linked to the University of Indonesia. Today, Unhas focuses on advancing science, technology, arts, and culture, with a strong emphasis on the Indonesian Maritime Continent, aiming to develop innovative and globally competitive graduates.
Learn more, here: https://www.unhas.ac.id/about/

About Dr. Heryanto Heryanto from Hasanuddin University, Indonesia
Dr. Heryanto Heryanto is a lecturer and researcher in the Department of Physics at Hasanuddin University, Indonesia. His research expertise spans material physics, composite materials, nanomaterials, and computational materials science, integrating experimental characterization with computational approaches to understand and design advanced functional materials. He has more than 175 publications to his credit with close to 2,000 citations.

Funding information
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.